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Brown adipose tissue (BAT) is a crucial regulator in energy expenditure by dissipating
energy in the form of heat through mitochondrial uncoupling protein 1 (UCP1). Previously,
we demonstrated that n-3 PUFA (Omega-3 Polyunsaturated Fatty Acids) increase brown
adipogenesis by miRNA-mediated epigenetic mechanisms. Given that BAT is formed at
the late stage of pregnancy, we hypothesized prenatal exposure of n-3 PUFA through
maternal nutrition potentiates BAT development. To test this hypothesis, Female C57BL/6
mice were fed a diet containing n-3 PUFA (3%) derived from fish oil (FO), or an isocaloric
diet devoid of n-3 PUFA (Cont), and same diet was maintained throughout the pregnancy
and lactation. Results showed that maternal FO was effectively delivered to the offspring
significantly reducing n-6/n-3 ratio, altered blood lipid profile, and upregulated brown
adipose tissue specific genes and proteins. The elevated levels of brown adipose tissue
signature gene profiles, i.e., Uncoupling protein 1 (UCP1), Peroxisome proliferatoractivated receptor gamma coactivator 1-alpha (PGC1-α), in weaned pups with maternal FO
intake were correlated with higher expression of GPR120 and the functional cluster of
brown-specific miRNAs including miR30b and miR193b/365. Intriguingly, augmented
BAT development in offspring by maternal FO intake was also associated with 1) increased
epigenetic marks at H3K27Ac and H3K9me2, and decreased histone deacetylase 1

(HDAC1), and 2) upregulation of Drosha, which is a miRNA-editing enzyme for premiRNA production. More importantly, benefits of maternal FO intake remained later in
life showing that pups that received maternal FO presented a lower body weight at
weaning, an increase in energy expenditure and higher core body temperature against acute
cold exposure in later life. Taken together, our results indicated that prenatal exposure to
n-3 PUFA potentiates the offspring’s BAT development, at least partly via synergistic
epigenetic modifications in histone modifications and miRNA production, which may
confer long-lasting metabolic benefits to offspring.
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CHAPTER 1. LITERATURE REVIEW
The epidemic of obesity is on the rise all around the world according to the global
estimates made by World Health Organization (1). As is known, the development of
obesity is caused by an energy imbalance, resulting in the storage of excess energy in the
form of triglycerides. Obesity is commonly concurrent with insulin resistance and
hyperinsulinemia, which lead to the development of type 2 diabetes mellitus (2) (3). Brown
adipose tissue is a non-shivering thermogenic organ and it can generate heat to maintain
thermal homeostasis by uncoupling oxidative phosphorylation from ATP production via
mitochondrial uncoupling protein 1 (UCP1) (4). The classical brown adipocytes are found
in the interscapular brown adipose tissue which exists when offsprings are born and the
beige adipocytes are primarily found in subcutaneous white adipose tissue after adrenergic
stimulation, which are produced by external stimuli, cold or dietary factors. (5). Due to
the high efficiency in oxidizing glucose and fatty acids, and the recent discovery of its
existence in adult human (6), brown adipose tissue has a promising therapeutic potential to
combat obesity.
Adaptive thermogenesis is an energy-demanding process in which futile
uncoupled-respiration releases the mitochondrial proton gradient as heat. It is regulated by
a range of intrinsic and extrinsic factors including daily diet (7). Diet plays a first-line role
in regulating energy balance and adiposity. Beyond the obvious strategy of calorie
restriction, emerging evidence supports the thermogenic function of several food-derived
components. Dietary intervention is more likely a safe approach to modulate brown/beige
energetics compared to targeted activation of the3-adrenergic receptor (ADRB3) by
pharmacological interventions due to the increased risk of cardiovascular side effects (8).
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Nearly a dozen dietary polyphenolic compounds have been identified as candidate
molecules to stimulate brown/beige activation (7,9). For example, capsaicin (10), green tea
catechins (11-13), resveratrol (14,15), quercetin (16,17), flavan-3-ols (18), and berberine
(19) are reported to possess brown stimulatory property. However, low bioavailability of
dietary polyphenols poses a challenge in launching a readily translatable anti-obesity
approach through diet-induced thermogenesis.
1.1 N-3 polyunsaturated fatty acid
Dietary fat, as a vital macronutrient, participates in numerous biological activities
in mammals. Based on the carbon numbers, fatty acids can be categorized as short chain
(2-6C), medium chain (6-12C), long chain fatty acids (13-22C), and very long chain fatty
acids (more than 22C). Based on the number of double bond, fatty acids can also be
categorized as saturated, monounsaturated, and polyunsaturated fatty acids (20). Based on
the position of the first double bond near the methyl terminus, long chain polyunsaturated
fatty acids can be defined as n-3, n-6, and n-9 (21). Particularly, omega-3 polyunsaturated
fatty acids (n-3 PUFA) are essential fatty acids abundant in fish source and fish oil, mainly
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Another omega 3 fatty
acid, -linolenic acid (ALA), also exists in green leafy vegetables, nuts, soybeans, and
some seeds (20). Since n-3 PUFA cannot be synthesized in the body and the conversion
rate from ALA to EPA and DHA is limited and inefficient, it is necessary to supply
adequate amount from diet and supplementation (20). Recently, fish oil (n-3 PUFA)
supplementation, mainly EPA and DHA, has been demonstrated to exert health beneficial
effects against inflammatory, hyperlipidemic (22), autoimmune, and cardiovascular
disorders (23). Also, it is regarded as a healthy addition to the diet of diabetic patients (24).
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Particularly, previous researches have reported that eicosapentaenoic acid (EPA) reduces
high-fat (HF)-diet-induced obesity and insulin resistance in mice (25). Also, accumulating
evidences have supported that eicosapentaenoic acid (EPA), major n-3 PUFA contained in
fish oil, can promote brown thermogenic adipogenesis and adaptive thermogenesis (7,2528). However, the underlying mechanisms remain to be elucidated.
1.2 Proposed mechanism regarding n-3 PUFA and thermogenesis
1.2.1 Thermogenic function of n-3 PUFA through GPR120 activation
G-protein-coupled receptor 120 (GPR120) is a functional receptor/sensor of n-3
fatty acids (FA) (29). Upon binding of n-3 PUFA, GPR120 activates the heterodimeric
Gq subunit and subsequently induces diverse cellular responses via several second
messengers such as [Ca2+]i , cAMP, and diacylglycerol (DAG) (reviewed in (29,30)).
Adipocytes, but not preadipocytes, express high levels of GPR120 in the rank order of
BAT>> iWAT ~ eWAT > mWAT (31). In this section, we focus on the role of GPR120
activation by fish oil in governing brown/beige fat activation.
1.2.1.1 Activation of brown fat-specific transcriptional program by n-3 PUFA
Humans contain a measurable amount of classical brown fat that expresses
constitutively active uncoupling protein 1 (UCP1) compared to beige fat that has temporal
and reversible UCP1 activation dependent on environmental stimuli such as cold
temperature and excess nutrition (32). Provided the continuous nature of the thermogenic
function, a small increase of BAT mass and/or activity are thought to exert a profound
impact on overall energy expenditure. Classical brown fat is found in certain anatomical
depots such as the cervical, supraclavicular, perirenal, axillary, and paravertebral areas
(33).
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Several research groups including our laboratory have tested the possibility that
dietary fish oil or GPR120 agonists augment the mass and/or activity of classical brown fat
(26,31,34,35). As an in vitro model of brown adipocytes, Kim et al. isolated brown fat
precursor cells from the interscapular BAT (iBAT), and then n-3 PUFA (i.e., EPA and
DHA) were added during differentiation and compared with other fatty acids (oleic acid
and palmitic acid) (26). Treatment with 100 M of EPA and DHA, but not oleic and
palmitic acid, significantly promoted brown fat-specific transcriptional programming,
resulting in an increase of uncoupled respiration. Supporting these results, Pahlavani et al.
showed that EPA (50-100 M) treatment increased thermogenesis in HIB1B cells, brown
preadipocytes derived from a murine brown fat tumor (35). In addition, Kim el al.
demonstrated that EPA-induced transcriptional activation of brown adipogenesis relied on
microRNA (miRNA)-mediated epigenetic mechanisms in primary murine brown
adipocytes. Functional clusters of brown fat-specific miRNAs including miR193b/365,
miR30b, and miR378 were induced by EPA treatment (26). More importantly,
transcriptional activation of brown adipogenesis as well as miRNA production were
dependent on GPR120 signaling. Stimulation with GW9508, a GPR120 agonist,
recapitulated the effects of EPA. Conversely, depleting GPR120 expression by siRNA (26)
or genetic deletion (31), attenuated EPA-mediated activation of brown adipogenesis. These
data suggest that GPR120 signaling precedes the transcriptional activation of brown
adipogenesis, in part through miRNA-mediated epigenetic mechanisms.
The effects of EPA on BAT thermogenesis were validated in HF diet-fed C57BL/6
mice. EPA supplementation, either provided as pure EPA (35,36) or fish oil formulation
(24,26,31,34), reduced HF-diet induced obesity and metabolic dysfunction by increasing

5
thermogenic energy expenditure. In addition, these in vivo metabolic benefits were
concurrent with GPR120 activation and brown-specific miRNA production (26). A further
metabolic insight into the role of GPR120 on BAT thermogenesis was found in GPR120
null mice. These mice failed to upregulate cold-induced BAT genes and demonstrated loss
of brown fat-specific gene profiles and morphology, and ineffective maintenance of body
temperature with cold exposure (37). Taken together, these results suggest a novel
epigenetic signaling axis of EPA/GPR120/miRNAs is involved in regulating brown fat
function (26). In addition, GPR120-dependent FGF21 (fibroblast growth factor 21)
secretion was proposed to propagate the BAT-driven thermogenic responses to other
tissues, e.g., liver and muscle, via autocrine and paracrine signaling of FGF21 (31).
Rosell et al report an intriguing intrinsic feature of GPR120 in BAT (38). Cold
treatment itself promotes ~2-fold induction of GPR120 in BAT, but not in WAT (38),
suggesting that the intrinsic ligand for GPR120 may be synthesized in brown fat as a part
of cold adaptation. From this aspect, it is worthwhile to dissect BAT lipid metabolism
during cold adaptation. In fact, n-3 PUFA is endogenously synthesized in brown fat, but
not in white fat, in mice and rats (39,40). In addition, Inuits, indigenous people of the
Canadian Arctic, possess selected alleles of fatty acids desaturases, thereby facilitating
endogenous n-3 PUFA synthesis (41). Moreover, an induction of GPR120 by fish oil intake
synergistically promotes thermogenesis compared to cold exposure alone (26,38). The
elevated levels of n-3 PUFA in BAT via endogenous biosynthesis as well as high fish
consumption would synergistically contribute to keeping Inuits warm against cold
temperature by promoting brown thermogenesis. Further research is warranted to
understand the exact nature of cold-induced GPR120 induction in BAT in the context of
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lipid profile changes, n-6/n-3 ratio, membrane fluidity, and thermogenic heat release.
In conclusion, GPR120 activation, either by endogenous synthesis of n-3 PUFA in
cold or by dietary n-3 supplementation, plays an essential role in boosting brown fatspecific transcriptional programming including miRNA-mediated epigenetic mechanisms
and FGF21 signaling (Figure 1A).
1.2.1.2 Role of GPR120 activation in beige fat differentiation by n-3 PUFA
Oh et al. first demonstrated that white adipocytes express high levels of GPR120,
but not GPR40 (42). The stimulation of GPR120 by n-3 PUFA, or its chemical agonist,
promotes glucose uptake by sensitizing insulin signaling (29). Supporting this notion,
genetic ablation of GPR120 in mice results in hepatic steatosis and insulin resistance (43).
In humans, lack of GPR120 signaling activity due to a genetic mutation in the GPR120
gene (p.R2700H) is correlated with increased risk of obesity (43). Despite several
controversies surrounding the anti-obesogenic role of GPR120 in humans, evidence
derived from experimental animals indicates that GPR120 activation increases lipid
combustion and reduces adiposity.
Several groups of scientists provided direct evidence that fish oil promotes beige fat
development from adipogenic precursor cells (24,28,37,44,45). Zhao et al first reported
that 200 M EPA treatment of stromal vascular (SV) cells isolated from mouse inguinal
fat effectively induced beige-specific signature gene profiles, and increased mitochondrial
energy expenditure (28). Laigelesia et al investigated the metabolic effects of EPA (100200M) on human adipogenic stem cells isolated from subcutaneous fat. Incubation with
EPA (100-200M) during adipogenic differentiation promoted mitochondrial biogenesis
and induced thermogenic gene expression and specific beige markers such as CD137 (37).
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Similarly, Fleckenstein-Elsen et al demonstrated that EPA, but not arachidonic acid (ARA,
C20:4n-6), promoted beige adipocyte formation from primary hADS (45). The conversion
of uncommitted SV cells into beige fat by fish oil is GPR120 dependent. Treatment with
GW9508, a chemical agonist of GPR120, recapitulated the white-to-beige conversion by
fish oil (31). Conversely, beige conversion by EPA was abolished in SV cells prepared
from GPR120 null mice or in the presence of AH7614, a chemical antagonist of GPR120
(31). However, GPR120 activation by EPA in fully-mature white adipocytes does not
cause beige conversion, suggesting that EPA acts on beige adipocyte recruitment rather
than by promoting trans-differentiation (28).
The involvement of GPR120 in beige adipocyte differentiation was further
confirmed in animal studies. Quesada-Lopez et al. demonstrated that feeding adult mice
with GW9508 for 7 days, significantly upregulated thermogenic genes (i.e., UCP1,
PGC1, FGF21, SIRT3), and caused browning of inguinal WAT (iWAT) (31). The
simultaneous administration of CL316243, a3-specific adrenergic receptor agonist, with
GW9508 showed a synergistic increase in oxygen consumption rate and browning of
WAT. In contrast, genetic ablation of GPR120 completely abolished cold- and3 agonistinduced WAT browning. This particular study demonstrated that elevated levels of FGF21
are linked with GPR120 activation in both WAT and BAT, suggesting a novel signaling
axis in which adipocyte GPR120 links with FGF21, a key endocrine hormone for fatty acid
oxidation (31). Consistent with this study, TUG-891, another GPR120-specific agonist,
significantly promotes fat oxidation and adipocyte browning through Gq-mediated
calcium release, mitochondrial depolarization, and mitochondrial fission (46). In summary,
multiple pathways work in concert to facilitate beige fat induction through GPR120
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activation via either dietary n-3 PUFA supplementation or by chemical agonism (Figure
1B).
1.2.1.3 Regulation of innate immunity by n-3 PUFA in beige fat differentiation
White adipose tissue is an important endocrine organ releasing numerous
adipokines that can alter inflammatory status and insulin sensitivity. Adipose tissue
inflammation is mediated by the inflammatory responses of adipose tissue macrophages
(ATMs). Oh et al. demonstrated the anti-inflammatory function of GPR120 in adipose
tissue (42). Activation of GPR120 by n-3 PUFA or chemical agonists preferentially
promotes anti-inflammatory M2 macrophage polarization and protects from HF dietinduced metabolic dysfunction (42). In the context of WAT browning, the physiological
relevance of type 2 innate immune responses has been recently highlighted (47). ADRB3
pathway activation by cold stress initiates type 2 innate immune responses and alternative
M2 macrophage polarization, which mediates UCP1-positive beige fat development. M2
macrophages have been shown to provide local catecholamine within WAT (21). In
addition, groups of type 2 innate lymphoid cells (ILC2s) and eosinophils are the major
source of type 2 cytokines IL-33, IL-4, and IL-13 that are necessary for proliferation and
commitment of beige precursor cells into beige adipocytes (48,49). Despite numerous
indications, a missing link remains as to whether fish oil supplementation (or GPR120
activation itself) amends the immunological makeup of WAT into a favorable state for
proliferation of beige progenitor cells.
New evidence suggests FGF21 is an important mediator for type 2 innate immune
responses in WAT. Huang et al. reported that FGF21 acts on adipocytes in an autocrine
manner to promote the production of CCL11, which subsequently promotes eosinophil
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recruitment, IL-4 release, M2 macrophage polarization, and proliferation and
differentiation of beige progenitor cells into thermogenic beige fat cells (50). Consistently,
Quesada-Lopez et al. have demonstrated that GPR120 activation failed to induce beige fat
induction in FGF21 null mice and vice versa (31), suggesting that a GPR120/FGF21 axis
is essential for WAT browning. Given the indispensable function of GPR120 on FGF21
production, it is likely that fish oil-induced beige fat may trigger type 2 innate immune
responses and eosinophil recruitment in WAT. To validate this notion, it is necessary to
evaluate the signaling relay of FGF21/CCL11/type 2 lymphoid cells proposed by Huang et
al (50) in GPR120 null mice.
In summary, the activation of GPR120 in inguinal adipose tissue mediates the
production of FGF21, resulting in immunological remodeling of adipose tissue such as
recruitment of type 2 innate immune responses, recruitment of eosinophils, ILC2s and M2
macrophages, and proliferation of beige precursor cells. (Figure 1B).
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Figure 1 Activation of brown and beige thermogenesis by n-3 PUFA by GPR120dependent mechanisms
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1.2.2 Thermogenic activation by n-3 PUFA through GPR120-independent
mechanisms
1.2.2.1 Thermogenic activation by n-3 PUFA through TRPV1
N-3 PUFA supplementation triggers multiple signaling pathways for thermogenic
reprogramming, which GPR120 activation alone cannot explain. Activation of the
sympathetic nervous system (SNS) plays a critical role in non-shivering thermogenesis by
innervating BAT and, to a lesser extent, WAT. Detected in the skin, cold is a strong
afferent signal to stimulate the SNS in the hypothalamus. Stimulation of the SNS induces
efferent signaling acting upon BAT and WAT to produce catecholamines, which activate
3-adrenergic receptors (ADRB3), produce cAMP, and thereby triggers the thermogenic
program (51). Though the sympathetic outflow signaling to BAT/WAT could be identical,
the afferent signal to SNS by food-borne molecules originates from temperature-sensing
mechanism in the gut (52,53). An example of a dietary component is capsaicin, the major
pungent component in hot red peppers. Dr. Saito’s group has extensively investigated the
ability of capsaicin (or capsinoids) to bind to transient receptor potential vanilloid
1 (TRPV1), a nonselective calcium channel located on peripheral sensory neurons in the
gut, sending out a thermogenic stimulus to the SNS (10,54,55).
Similar to capsaicin, fish oil induces brown/beige fat through activation of the SNS.
Kim et al. demonstrated that fish oil supplementation for 10 weeks increased oxygen
consumption and core body temperature in mice (24), which was abolished by propranolol,
a potent -blocker. Consistently, elevated levels of cAMP in serum and peripheral tissue
after fish oil consumption was reported (24,26). The gut-brain-adipose tissue axis seems to
be essential, as evidenced by browning effects were abolished in mice with the removal of
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the vagal nerve, vagotomy, or genetic deletion of TRPV1 (24). In agreement with this
notion, n-3 PUFAs are well-known ligands for TRPV1 (56). Ohyama et al. proposed new
evidence that capsaicin-mediated TRPV1/SNS axis activation may stimulate 2adrenoceptors (ADRB2) in white fat rather than the 3-adrenoceptor. Furthermore, this
study demonstrated that synergistic SNS activation by sub-ambient temperature (17°C) and
TRPV1 activation in the gut by capsaicin strongly enhanced WAT browning, resulting in
> 2-fold weight loss relative to that caused by cold or capsaicin alone (57).
Collectively, these studies suggest that n-3 PUFA, independent of GPR120mediated signaling, serve as a stimulator for TRPV1 in the gut, activating the SNS to
trigger ADRB3-mediated signaling cascades in both BAT and WAT (Figure 2A). It is
worth testing whether the combined strategy of chronic sub-ambient temperature and
dietary regimen with fish oil will constitute a practical approach to promote brown/beige
thermogenesis in humans.
1.2.2.2 Impact of n-3 PUFA-driven oxylipins on thermogenic activation of beige
adipocytes
The Western diet is deficient in n-3 fatty acids (n-6/n-3=15~17), and a high ratio
of dietary n-6/n-3 is associated with increased risk of various metabolic diseases including
obesity (58). Pisani et al first addressed the impact of n-6/n-3 ratio on beige fat conversion
(59). By using hADS, it has been shown that n-6 PUFA, i.e., linoleic acid (LA, C18:2n-6)
and arachidonic acid (ARA, C20:4n-6), strongly inhibit adipocyte browning. This
inhibitory effect was associated with ARA-derived eicosanoids of PGE2 and PGF2 via
cyclooxygenase (COX) activity (59). Ghandour et al have compared the effective
thermogenic potential of a n-6 enriched diet (n-6/n-3=30) composed of linoleic acid (LA,
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C18:2n-6) and oleic acid (OA, C18:1n-6) with an n-3 supplemented diet (n-6/n-3=3.7)
mostly composed of alpha-linolenic acid (ALA, C18:n-3) (60). This study revealed that n2 prostaglandin series derived from n-6 PUFA, i.e., PGF2 and PGE2, were inhibitors of
adaptive thermogenesis. More importantly, it was proposed that a high intake of n-3 PUFA
and its oxygenated lipid mediator prostacyclin (PGI2) promotes beige fat formation by
suppressing PGE2 and PGF2 production in adipocytes, implicating the competition
between n-3 vs. n-6 FA for COX activities (60). In accord with this idea, PGI2 or a stable
analog of prostacyclin promotes browning of hADS through mechanisms associated with
cognate receptor IP-R/cAMP signaling and upregulation of PPAR (61). Taken together,
these studies suggest that the n-6/n-3 ratio per se is an important modulator for white-tobeige thermogenic conversion through oxygenated lipid mediators (oxylipins) independent
of GPR120-mediated signaling cascades (Figure 2B).
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Figure 2 Activation of brown and beige thermogenesis by n-3 PUFA by GPR120independent mechanisms.
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1.3 Current knowledge, controversies, and directions for future research
We summarized recent studies that investigated the role of n-3 PUFA in influencing
thermogenic function in animals and relevant cell models of brown and beige adipocytes.
n-3 PUFA possess unique properties to promote brown/beige thermogenesis compared to
other long-chain saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), or n-6
PUFA (26,45). This agrees with literature suggesting that n-3 PUFA are better ligands for
GPR120 than n-6 PUFA (29). Moreover, these data are consistent with recent results that
metabolites of n-3 PUFA are much more potent agonists for the TRPV1 receptor than
metabolites of ARA (62). n-3 PUFA seemingly exhibit distinctive mechanisms on brown
vs. beige precursor cells, although GPR120 is involved in both brown and beige fat
development. Based on literature, we suggest a molecular framework that n-3 PUFA act
on brown precursor cells at the transcriptional level during brown adipogenesis (Figure
1A), whereas n-3 PUFA alter the microenvironment of WAT at the level of recruitment
and proliferation of beige precursors (Figure 1B). In agreement with this current
hypothesis, trans-differentiation of white to beige adipocytes was not triggered by n-3
PUFA (28). Herein we categorized 3-specific adrenergic receptor activation by n-3
PUFA as a GPR120-independent pathway. Given that adaptive thermogenesis is an
integrative response linking the central nervous system to peripheral adipose tissues, the
activation of sympathetic neurons by n-3 PUFA can be regarded as a concurrent and
synergistic signal parallel to the GPR120-dependent peripheral responses rather than
exclusive to each other.
One important but unanswered question is the thermogenic effectiveness among
the different dietary n-3 PUFA, i.e., DHA, EPA, ALA or docosapentaenoic acid (DPA,
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C22:5n-3). To date, most studies tested the thermogenic function of n-3 PUFA by using
fish oil that contains mixtures of EPA and DHA, and no study was conducted to evaluate
the thermogenic function of ALA or DPA alone. Despite some controversies, EPA seems
to be a stronger thermogenic stimulus than DHA in general, based on studies on murine
brown adipocytes or hADS (26). One reasonable answer is found in studies conducted by
Dr. Pisani’s group. A fascinating hypothesis is proposed that oxylipins derived from
different PUFA are downstream effectors to modulate thermogenic remodeling of beige
fat. In particular, Pisani et al claimed that PGI2 is a pro-thermogenic eicosanoid wherein
EPA is a better substrate of COX for PGI2 production rather than DHA (63). Conversely,
it is suggested that DHA is insufficient to compete with ARA and less effective in
suppressing anti-adipogneic oxylipin production of PGF2 and PGE2, although DHA
features a stronger effect on inhibiting COX2 activity. This notion seems to align with the
several cohort studies demonstrating EPA, but not DHA, is effective in reducing
triglyceride levels in humans (64,65). However, the likelihood of the impact of n-6/n-3
ratio on beige fat development warrants additional support from other researchers, as all
studies were published from a single group (63-65). Also, it is uncertain how competition
between n-3 vs. n-6 PUFA toward COX activity affects recruitment of beige precursor or
the immunological setting of WAT. Further research is required to test these hypotheses in
a relevant system. For example, use of the transgenic fat-1 mouse that converts n-6 PUFA
into n-3 endogenously would be a useful model system to investigate the function of a low
n-6/n-3 ratio in regulating adaptive thermogenesis probably without the influence of
GPR120 signaling. Moreover, future studies to distinguish the thermogenic function of
plant-based n-3 PUFA, e.g., flaxseed oil or nut oil (rich in ALA), from marine-based fish
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oil (rich in DHA and EPA) would be essential to establish a solid role of a low n-6/n-3 ratio
in regulating adaptive thermogenesis.
There are some caveats since most cell-based studies used approximately 100-200
M of EPA, which may not be attainable by oral intake of a fish oil-containing diet or pills.
Nonetheless, these studies suggest a new research avenue that n-3 PUFA-enriched diets
possess the potential to alter the fate of adipogenic stem cells into mitochondria loaded,
fat-burning beige adipocytes rather than fat-depositing white adipocytes.
1.4 Human clinical studies supporting the thermogenic function of n-3 PUFA
The physiological relevance of brown/beige fat in obesity has been well established
in humans (66). It is estimated that healthy adults contain upward of ~60 g of brown/beige
fat (<0.1% of body weight), which could be responsible for >20 % of daily energy
expenditure (67). Unfortunately, induction of thermogenic fat in response to cold exposure
is severely compromised in obese individuals (68,69). Conversely, loss of thermogenic
activity, whether classical brown or beige fat, contributes to obesity. There are numerous
studies supporting that n-3 PUFA decreased inflammation and improved insulin sensitivity
in metabolically unhealthy humans (70-76). However, the implication of thermogenic
function of n-3 PUFA is less evident in human clinical trials, despite the clear indication
in the aforementioned animal studies. This is likely due to technical difficulties in
measuring thermogenic energy expenditure in humans; thus, few studies were designed to
assess thermogenic heat release or energy expenditure. In this section, we revisit some of
the previous human clinical trials showing that n-3 PUFA affect metabolic rates and
adiposity, which may help us provide insight into the thermogenic function of n-3 PUFA
in humans.
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1.4.1 Clinical evidence on the thermogenic function of n-3 PUFA
One of the most noticeable effects of n-3 PUFA supplementation is reduced fat
mass. Based on the meta-analysis involving 11 randomized clinical trials, Zhang et al
revealed that n-3 PUFA intake significantly reduced serum levels of triglyceride and waist
circumference without affecting body mass index (BMI) (77). Results reported from this
study confirm the potential function of n-3 PUFA on reducing visceral fat. However,
conclusions from this report are uncertain due to limitations, such as small-scale
randomization and poor quality control. The fat loss effect by fish oil was also noted in a
study of insulin-resistant adults conducted by Ramel et al (78). A total of 324 participants
aged 20-40 years with BMI 27.5-32.5 were randomly assigned 0-2.1g/day of n-3 PUFA for
8 weeks. This study revealed that 2.1g/day n-3 PUFA was linked to a significant decrease
in body weight, plasma levels of fasting insulin, glucose and triglyceride, and improved
insulin sensitivity (78). However, these studies were not designed to understand the
underlying mechanisms, and thus it is difficult to infer a thermogenic function of fish oil
solely due to reduced adiposity.
The very first crossover-study to determine the effects of n-3 PUFA on resting
metabolic rate (RMR), basal energy expenditure, and body composition was conducted by
Couet el al. Supplementation of 6g/day of fish oil for three weeks resulted in reduced body
fat mass. It also decreased respiratory exchange ratio (RER), indicating increased fuel
usage from fat, and increased basal lipid oxidation without altering resting metabolic rate
(79). This study posed several limitations such as small size (only six participants), gender
imbalance (5 males and one female), and seasonal differences between two cohorts. Noreen
et al. conducted another study to determine the oxidative potential after fish oil intake (80).
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In this study, 6 weeks of fish oil supplementation (4g/day) significantly increased lean body
mass and reduced fat mass in healthy adults (total of 44 men and 34 women), although
significant differences in basal metabolic rate (BMR) or RER were not observed (80). In
parallel with these results, the inclusion of fish or fish oil in randomized trials of weightloss-diets offered increased weight loss in healthy humans (81,82). Most recently, JannasVela et al. reported an interesting study (83) that determined the BMR and substrate
oxidation in young healthy males subjects after 12 weeks of fish oil supplementation (2g/d
EPA, 1g/d DHA) in comparison to olive oil intake. The authors identified that fish oil
intake increased fatty acid and carbohydrate oxidation in the winter season, but not in
summer, regardless of RMR. These results imply that fish oil-mediated thermogenic
activation may require additional environmental stimuli, such as cold temperature (83). In
the same context, the effects of n-3 PUFA were augmented with exercise (84), another
signaling factor to promote adaptive thermogenesis (85). Another important aspect to
consider is gender differences in WAT browning. In contrast to the study performed by
Jannas-Vela et al. (83), Logan et al. reported that 12 weeks of fish oil supplementation
(3g/day) significantly increased resting BMR as well as exercise-induced fat oxidation in
females (86). This result is also consistent with the finding that women contain a detectably
higher amount of brown fat mass than males (6).
1.4.2 Limitations of studies and directions for future research
The thermogenic effects of n-3 PUFA in human clinical trials, mostly fish oil
supplementation, remain inconclusive, despite a strong correlation between fish oil intake
and reduced visceral adiposity. The inconsistency between animal studies and human
clinical trials seems to originate from the confounding factors of study design and technical
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difficulties in brown fat identification in humans. Unlike experimental design for rodents,
direct stimulation of ADRB3 via pharmacological agonists or chronic exposure to
suboptimal low temperature is not appropriate for human clinical trials. Hence, better study
designs are required to address the thermogenic function of n-3 PUFA intake in adaptive
thermogenesis in humans. In agreement with this notion, the reduced adiposity by fish oil
supplementation seems to become increasingly evident with additional signaling cues for
thermogenesis such as calorie restriction, cold temperature, and exercise (81-83).
Therefore, fish oil supplementation in combination with other lifestyle modifications could
be a better strategy to promote adaptive thermogenesis. This hypothesis needs further
research with well-controlled and large-scale human trials in both genders. In addition,
direct evidence such as
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F-2-deoxy-glucose (FDG) uptake using positron emission

tomography (PET)-scans should be provided to establish stronger links with adaptive
thermogenesis in humans (87).
1.5 Prenatal exposure of n-3 PUFA, BAT development, and childhood obesity
Pregnancy, especially in the late gestation period, is the critical window of time for
fetal growth including classical BAT development. Augmentation of classical BAT
development at the time of birth and increased retention in childhood could be a promising
intervention strategy to counteract obesity and metabolic syndrome. Until now, several
non-nutritional factors have been shown to increase the development of BAT formation in
the fetus. These include thyroid hormone, catecholamines (88,89) or maternal cold
exposure (90), suggesting that activation of maternal sympathetic innervation promotes
ADRB3 signaling in the fetus, thereby enhancing the development of BAT. Currently,
there is growing information that maternal or infant nutritional status alters BAT
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mass/activity in newborns and its maintenance in adulthood. Malnutrition at late
gestational phases, such as low protein intake (91-93) or HF diet (94), results in reduced
BAT development in animal models.
Maternal supplementation of n-3 PUFA increases the n-3 PUFA concentration in
the placenta and uterus cord blood, suggesting that n-3 PUFA are effectively transferred to
the fetus in utero (95). Pregnant women are recommended to take 600~800 mg of n-3
PUFA daily during pregnancy, and no adverse effects were found with up to 2.8 g/day of
n-3 PUFA at the late gestation period until delivery (96). Several human studies report a
negative correlation between maternal n-3 PUFA intake and prevalence of childhood
obesity (97-100). In a large population-based cohort study with 4830 mothers, Vidakovic
et al. showed that higher maternal n-6/n-3 ratio was correlated with higher risk of childhood
obesity (97). In another prospective cohort study, Moon et al. identified that maternal n-3
FA intake was associated with offspring lean body mass in 12,583 participants (99). More
interestingly, a long-term follow-up study showed that fish oil supplementation during
pregnancy in obese mothers had long-lasting effects on reduced adiposity in their offspring
(100). Intriguingly, a recent study by Rudolph et al. supports this model demonstrating that
low perinatal n-6/n-3 ratio serves as a metabolic cue to attenuate the susceptibility against
diet-induced obesity in adult offspring (101).
Based on these results, it is conceivable that maternal fish oil intake may promote
prenatal BAT reprogramming via the aforementioned mechanisms or may delay the
postnatal degeneration of BAT in early life (Figure 3A). Our group is currently undertaking
a pilot study to address the metabolic benefit of maternal n-3 PUFA nutrition on fetal BAT
development in animals. While our results are promising, this possibility is still to be
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reported in the primary literature. In addition, the broader implications of maternal n-3
PUFA supplementation on gestational diabetes, obesity outcomes, and BAT activity in
mothers in addition to infants remains to be determined in the context of thermogenic
activation.
1.6 N-3 PUFA supplementation and aging-mediated reduction in thermogenesis
The probability to detect brown/beige adipose tissue is inversely correlated with
age, implying that thermogenic potential declines with senescence (6). Understanding the
exact cause and identifying an intervention strategy to revert this thermogenic reduction
have strong clinical implications for improving metabolic health. Berry et al. have found
that old mice (1-year-old) failed to activate cold-induced beige thermogenesis compared to
young mice (2-month-old) (102). They identified that 1) cellular aging of beige progenitors
is driven by cell cycle inhibitors (i.e., p21cip and p16Ink4a, and p19Arf) and stressactivated kinases p38, and 2) senescent beige precursors are unable to proliferate and
differentiate upon cold stimulus. Blockade of cellular senescence by genetic deletion of
Ink4a/Arf or a small molecule inhibitor of p38 reversed the aging-mediated decrease in
thermogenesis (102).
Based on the proposed mechanism above, dietary molecules that possess the ability
to suppress cellular senescence of beige precursor cells could be effective in rejuvenating
WAT-browning with aging. Compared to other health benefits, the anti-aging function of
n-3 PUFA is less clear and poorly understood (103). Although the exact mechanism was
not presented, several clinical trials have reported anti-aging effects of n-3 PUFA; marine
n-3 PUFA intake (DHA+EPA) was associated with significant attenuation of telomere
shortening in patients with coronary artery disease (104) and elderly individuals (105).
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Regarding this mechanism, Chen et al. revealed that fish oil supplementation suppressed
aging-mediated reduced-telomere activity by maintaining redox homeostasis; DHA intake
was effective in suppressing overexpression of p16 and p53, which are metabolic culprits
to promote cellular senescence (106). Supporting this concept, fish oil supplementation
improved energy expenditure and promoted RMR in elderly females (86). It remains to be
determined whether the proposed axis activation of ‘redox-telomere-cell cycle inhibition’
will be relevant to beige precursor cells (Figure 3B).

Figure 3 Nutritional perspectives regarding n-3 PUFA intake on thermogenic
activity during pregnancy and senescence.
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CHAPTER 2. EXPERIMENTS AND RESULTS
2.1 Introduction
Brown adipose tissue (BAT) is a specialized fat that dissipates excess energy into heat
(non-shivering thermogenesis) through mitochondrial uncoupling protein 1 (UCP1) (107).
Current research renews the metabolic function of BAT by revealing BAT as a crucial
regulator in maintaining energy balance by increasing thermogenic energy expenditure. A
significant amount of BAT is found in healthy adults as well as most children and
adolescents (6,108,109), but not in the obese adults, suggesting that loss of active BAT
depots is a contributing factor to obesity. Childhood obesity predisposes adults with
metabolic susceptibility to obesity and type 2 diabetes (T2D) (1,110,111). Therefore,
identifying early regulatory factors to prevent childhood obesity is critical to combat the
current obesity epidemic. The fetal and neonatal stages are critical for fetal BAT
development, which are expected to have long-term impacts on offspring BAT function
(112). However, limited amount of studies has been conducted regarding the effect
maternal nutrition on prenatal development of BAT. The status of n-3 PUFA is important
to fetus as determining factors of health and disease in both infancy and later life (113).
During the pregnancy stage, mother’s metabolism needs to be adapted in order to satisfy
the continuous draining of substrates and the proper growth and development of the fetus
(114). Despite the well-established physiological relevance of BAT in obesity outcome, it
is unclear whether the amount of BAT at birth or the rate of BAT loss (either by
degeneration or by transdifferentiation into WAT) are associated with susceptibility to
obesity in later life. In particular, it is poorly understood whether prenatal BAT
development through dietary intervention could be a manageable target to attenuate the
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risk for childhood obesity.
Human BAT depots are found in the deeper neck (cervical), supraclavicular,
paravertebral, perirenal, and axillary areas (115-117) and possesses 50-times greater
respiratory activities than white adipose tissue (WAT) (2). These BAT depots are
comprised of 1.5% of total body mass (roughly 5% of total fat mass), and up to 90% depots
could be activated BAT (118). An image-guided mapping of rodent adipose depots reveals
the topological analogy of BAT between rodents and humans (119), which provides the
feasibility to use rodent in studying human BAT. Also, the comparable functional analysis
demonstrated that human supraclavicular BAT features functional similarity with rodent
interscapular BAT regarding mitochondrial activity and thermogenic potential (2).
Regarding the timeline for BAT development, late pregnancy (at the last trimester) is the
critical time for human BAT formation (4,120). The human brown adipocytes in the
interscapular are rapidly lost after birth via either degeneration and replacement with white
adipocyte, or transdifferentiation into white adipocytes. However, brown adipocytes reside
in the deeper neck and supraclavicular regions, remain active to adolescence and adulthood
until they lost thermogenic potential with the progression of obesity, type 2 diabetes, or
aging (110). Given these developmental similarities, the regulation of interscapular BAT
in rodents during pregnancy seems to be translatable to BAT around the neck and
supraclavicular in humans.
BAT development is modulated by epigenetic modifications that are heritable and
reversible changes in gene expression occur without altering DNA sequences through DNA
methylation, chromatin histone remodeling, and noncoding RNAs such as miRNAs (121123). Nearly a dozen miRNAs have been identified in promoting the transcriptional
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program of brown adipogenesis (124). On the other hand, the site-specific acetylation (Ac)
and methylation (Me) status on the lysine (K) residues of histone tails, especially at H3K9
and H3K27, play essential roles in adipogenesis by controlling gene activation or
repression(125,126). Maternal nutrition is a key epigenetic modulator for fetus
development. However, it is largely unknown whether the BAT epigenome is a viable
target for obesity control through maternal nutrition.
Accumulating evidence has supported that n-3 PUFA promotes brown adipogenesis
and adaptive thermogenesis (7,25,27,28,127). We have previously demonstrated that
eicosapentaenoic acids (EPA) promote the brown adipogenic program through a miRNAdependent epigenetic mechanism in the murine primary brown adipocytes (26), suggesting
that maternal n-3 PUFA nutrition may be effective in reinforcing embryonic BAT
developmental program during pregnancy. This study aimed to investigate the impact of
early n-3 PUFA exposure through maternal nutrition on the fetal BAT development. Here,
we demonstrate that maternal n-3 PUFA intake during pregnancy and lactation enhanced
brown transcriptional programming through miRNA and histone modification-mediated
epigenetic regulations. These results open a new research avenue emphasizing that
‘boosting prenatal BAT development’ could be a novel therapeutic target for attenuating
childhood obesity through thermogenic energy expenditure.
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2.2 Central Hypothesis, Purpose, and Specific Aims
A. Purpose of the Study
The purpose of the study is to investigate the effect and the underlying mechanisms
of maternal n-3 PUFA supplementation on fetal brown adipose tissue development and
risks for obesity and long-lasting metabolic benefits.
B. Central Hypothesis
Maternal supplementation of n-3 PUFA during pregnancy and lactation promotes
the embryonic BAT development of neonates, thereby increasing the postnatal BAT
retainment and decreasing the risk of obesity and T2D in later life.
C. Specific Aims
Specific Aim 1: Investigate the effect and underlying epigenetic mechanism of maternal
n-3 PUFA supplementation during gestation and lactation on offspring’s brown adipose
tissue development and thermogenic activity in C57BL/6 mice.

Specific Aim 2: Identify the metabolic significance of maternal n-3 PUFA
supplementation in postnatal BAT retainment and long-term metabolic benefits.

Specific Aim 3: Evaluate the metabolic benefits of maternal n-3 PUFA intake during
pregnancy and lactation in the mother mice.

2.3 Materials and Methods
Animals
All animal experiments were conducted according to the protocols approved by the
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Institutional Animal Care and Use Committee (IACUC) at the University of NebraskaLincoln. C57BL/6 male and female mice were purchased at 8-10 weeks of age from the
Jackson Laboratory. After 3 days of acclimatization period, mice were put into the breeding
colony. Female mice were randomly assigned to two diet groups receiving either a diet
containing 3% of n-3 PUFA from the fish oil (FO) or a diet devoid of n-3 PUFA (Cont).
The AIN-93G rodent formulation was modified for the fat composition containing 15% of
total calorie from fat either 10% palm oil (Cont) or fish oil (FO), the other 5% of total
calorie from soybean oil as a source of essential FA. Gas Chromatography (GC) was used
to analyze fatty acid profiles of each diet and dietary composition in Table 1. The same
diets were maintained throughout gestation and lactation. The pregnancy of the female
mice last for 19-21 days, and the pups (n=18 each group) were weaned (3 weeks
postpartum). Necropsy was conducted at weaning, to collect blood, liver, interscapular
BAT (iBAT), and inguinal (iWAT) and epididymal WAT (eWAT). Tissue samples were
snap-frozen in liquid nitrogen and kept at -80 °C for further analysis.
Energy expenditure by metabolic cage
To measure the effect of maternal n-3 PUFA intake on energy expenditure, pups
(n=5 each group) were individually placed into the metabolic cage (TSE systems) for six
days (two days of adaptation and four days of measurement). Indirect oxygen consumption
(VO2) and carbon dioxide production (VCO2) were used to calculate metabolic
parameters. Energy expenditure (EE) and respiratory exchange rate (RER=VCO2/VO2)
were calculated and obtained from the TSE systems software and plotted into a figure with
hourly time point.
Cold exposure, measurement of rectal temperature and heat release
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To measure the long-term effect of maternal n-3 PUFA supplementation on the
offspring’s thermogenic potential, male pups from both maternal fish oil or control diet
(n=6 per group) were switched to a standard AIN-93G diet (no additional n-3 PUFA). At
week 11, mice were exposed to cold temperature (6°C) acutely (1-3 hour) or for 24 hours.
To measure the core body temperature, a rectal thermometer (Kent Scientific Corp) was
used. The probe was positioned into the anal ducts of the mice and three readings of each
time point were recorded. Infrared (IR) camera (A655sc, FLIR Systems) was used to detect
thermal release and to capture images of the surface body temperature. FLIR Research IR
program software was used to display surface heat release via color palette representing
temperatures between 22 and 34 °C.
Gas Chromatography (GC) for fatty acid analysis
To determine FA profiles in the red blood cells, whole blood was collected, and red
blood cells were precipitated by centrifugation (6000×g for 15 minutes). 200l of the
packed volume of red blood cells were transferred to a fresh glass vial and total lipids were
extracted. They were then subjected to FA methylation by 14 % boron trifluoride (BF3)methanol reagent (Sigma, USA) at 100 °C for 1 hour to form fatty acid methyl ester
(FAME). Agilent Technologies HP-88 column (100m x 0.25mm x 0.2 μm film thickness)
was used. The individual FA peak was identified by comparing its relative retention times
with the commercial mixed-FA standard (NuCheck PreP), and the area percentages for all
resolved peaks were analyzed using the GC Chemstation software.
Blood Chemistry
To measure plasma glucose, insulin, and cAMP levels, immunoassays were
conducted by using mouse glucose assay (Crystal Chem), ultra-sensitive mouse insulin
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ELISA kit (Crystal Chem), and mouse cyclic adenosine monophosphate (cAMP)
parameter assay kit (R&D Systems), respectively, in accordance to the manufacturer’s
protocol.
qPCR of mRNA and microRNA analysis
Total RNA was extracted using Trizol® reagent (Invitrogen) from homogenized
tissues. RNA was purified using DNase treatment & removal kit (Invitrogen), and 2 µg of
RNA was converted into cDNA (iScript, BioRad) via reverse transcription. Relative gene
expressions were determined based on the 2ΔΔCT method with normalization of the raw Ct
value to 18s. For miRNA analysis, miRNA was converted to cDNA using the miScript
reverse transcription kit (Qiagen) according to the manufacturer’s instructions. MiRNA
was measured by using the commercial miScript Universal Primer, with the miScript
primer assay kit (Qiagen). Primers of miR-30b, -193b, -365, and RNU6-2 were purchased
from Qiagen. The Ct values were normalized to RNU6-2 (U6 small nuclear).
Western blot analysis
Total protein was extracted from tissue by homogenizer using RIPA buffer along
with a protease inhibitor and phosphatase inhibitor. Proteins were separated by SDS-PAGE
and transferred onto polyvinylidene fluoride (PVDF) membrane (0.45 μm, Thermogenic
Scientific) using a wet-transfer method. Antibody targeting UCP1 (14670), PPAR (2444)
and -actin (4967) were purchased from Cell Signaling Technology. PRDM16 (sc-55697)
was purchased from Santa Cruz Biotechnology. Blots were visualized with a
FluorChemTME imaging system (Protein Simple).
Chromatin immunoprecipitation assay (ChIP)
The murine brown adipocyte cell-line (HIB1B) was a generous gift from Dr.

31
Johannes Klein (University of Lubeck, Lubeck, Germany), who has generated the cell line
from brown fat of newborn or 6-8 week old of C57BL/6 or FVB mice (128). HIB1B cells
were differentiated and treated with EPA (100 𝜇M), as we described previously (26).
Chromatin immunoprecipitation assay was performed using CHIP-IT® Express kit
according to the manufacturer’s instructions (Active Motif, USA). Cells were fixed with
1% formaldehyde to cross-link DNA and proteins. Chromatins were isolated and DNA was
sheared into 200-1000 bp length. Fifty l of each sample was removed as the input control.
The samples were incubated with magnetic beads-AcH3K27 antibody complex (Cell
Signaling Technology, USA) overnight. Next, magnetic beads were washed, and
chromatins were eluted and reversely cross-linked. After treated with Proteinase K, DNA
was ready to be used immediately for real-time qPCR analysis using SYBR Green
(QuantStudio 6, life technology). The Ucp1 and Pgcpromoter regions were assessed in
acetylation histone 3 at lysine 27 (H3K27) ChIP samples. Fold of enrichment was
calculated and presented according to the methods provided by the manufacturer.
Primer sequence: Ucp1 proximal promoter, 5’-CCCACTAGCAGCTCTTTGGA3’ and 5’-CTGTGGAGCAGCTCAAAGGT-3’; Pgc1CRE region, 5’CAAAGCTGGCTTCAGTCACA-3’ and 5’-AAAAGTAGGCTGGGCTGTCA-3’ (129).
Liver triglycerides content
Total liver lipids were extracted from 100mg liver tissue (n=4 each group) using
Folch method by adding chloroform/methanol with the ratio 2:1. After extracted at 60℃
for 2 hours and filtered through 70mm (Whatman) in glass funnels, 1% Triton X-100 was
added (Fisher BioReagents). Subsequently, samples were dried under nitrogen at 60℃, and
were resuspended in nucleus free water for further analysis. Triglyceride content was
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measured by the commercial TG quantification colorimetric kit (BioVision).
Statistical Analysis
All data are presented as mean ± SEM. Independent samples from control group and
treatment group were analyzed and compared using two-tailed Student’s t-test, with * P <
0.05, ** P < 0.01, *** P <0.001. All statistical analyses were conducted by Graph Pad
Prism 7 (Version 7.03).
2.4 Results
2.4.1 Maternal n-3 PUFA supplementation decreased WAT mass and n-6/n-3 ratio
To investigate the effects of n-3 PUFA on BAT development on offspring,
C57BL/6 female were fed either a diet containing with 3% of n-3 PUFA from fish oil (FO)
or an isocaloric diet absent of additional n-3 PUFA (Cont) during pregnancy and lactation.
Both male and female pups were weaned at 3 weeks postpartum. There was a significant
decrease in body weight in FO compared to Cont in both genders. Although there was no
difference in liver weight, WAT was significantly reduced in both genders, indicating that
maternal n-3 PUFA intake decreased white fat accumulation. A similar trend was observed
in iBAT mass, although the differences did not reach a statistical significance (Fig 4A-C).
To investigate the impact of maternal n-3 PUFA intake in the pups, FA profile was
determined in the red blood cells of the weaned pups. There was a significant decrease in
n-6/n-3 PUFA ratio in the maternal n-3 PUFA received group (FO) compared to the
control, indicating that maternal n-3 PUFA was effectively delivered from mothers to the
pups (Fig 4D). Concomitantly, the content of arachidonic acid (ARA), a precursor for proinflammatory eicosanoids, was significantly decreased in the maternal n-3 PUFA group
(Fig 4E). Also, there was a trend towards a decrease in plasma glucose (p=0.09) and insulin
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concentrations (p=0.1) in the maternal n-3 PUFA group (Fig 4F, G), indicating that
maternal n-3 PUFA intake may have an impact on the glucose tolerance and insulin
sensitivity in pups at weaning. Adrenaline, released via the action of the sympathetic
nervous system, plays a vital role in brown and beige adipose tissue thermogenic program
(130). Our results also indicated that there was a significant increase in cAMP levels
(p<0.01) in the plasma of FO group (Fig. 1H), which is a downstream target upon 3adrenergic receptor (ADRB3) activation, thereby regulating lipolysis and UCP1-mediated
thermogenic responses (131).
2.4.2 Maternal n-3 PUFA supplementation promoted the fetal BAT development
Despite there were no differences in iBAT mass, maternal n-3 PUFA intake was
linked with a darker in color in the picture of BAT taken upon sacrifice (Fig 5A), and lower
lipid accumulation in the H&E staining image (Fig 5B). Similar to the results from red
blood cells, maternal FO intake significantly altered the lipid profile in the iBAT with a 5fold reduction in n-6/n-3 ratio and a 2-fold decrease in ARA content compared to control
(Fig 5C). To identify the effect of maternal n-3 PUFA supplementation on BAT activities,
we measured the brown-specific gene expression levels in the iBAT. There was a
significant increase in Ucp1, Cidea, Prdm16, and Pgc1α, along with the Gpr120, a
membrane receptor of long chain fatty acid receptor in both gender pups (Fig. 5D-F). In
accordance with the increased brown-specific transcripts, protein expressions of UCP1,
PRDM16, and GRP120 were higher in the maternal FO-fed group (Fig 5G). The
mitochondrial DNA content showed a trendency towards an increase in the maternal n-3
PUFA group, but it was not statistically significant (p=0.08) (Fig 5H).
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2.4.3 Maternal n-3 PUFA supplementation modulated epigenetic factors for BAT
developments.
We have previously demonstrated that n-3 PUFA potentiate brown adipogenesis in
the primary murine brown precursor cells via miRNA-mediated epigenetic mechanisms
(26). After confirming that maternal n-3 PUFA upregulated BAT transcriptional programs
of the offspring (Fig 5), we sought to determine whether the similar epigenetic mechanisms
are involved in this process. The functional cluster of miRNAs of miR-30b, miR-193b, and
miR-365 was significantly increased in maternal FO received pups (Fig 6A), recapitulating
our in vitro results (26). Intriguingly, the BAT with maternal n-3 PUFA exposure showed
a substantial increase of Drosha, an RNA double-strand ribonuclease and critical
component of the microprocessor for initiating the cleavage of pri-miRNA into stem-loop
pre-miRNA (Fig 6B), in both gene and protein expression (Fig 6C, D). These results
suggest that nuclear processing of pri-miRNA might be upregulated by early exposure of
FO during fetal BAT development.
Next, we examined the role of maternal n-3 PUFA intake on histone modifications.
There was a remarkable decrease in histone deacetylase 1 (HDAC1). The reduced HADC1
levels were linked with an increase of acetylation (Ac), but a decrease of tri-methylation
(me3), at histone H3 lysine 27 (H3K27) site (Fig 7A), a critical post-translational
modifications (PTM) mark for brown adipogenesis(126). The decrease H3K27me3 was
consistent with decreased gene expression of JmjC domain-containing protein 3 (Jmjd3),
an H3K27-specific demethylase (132), in FO group compared to control (Fig 7B).
Intriguingly, no specific increase in acetylation levels at H3K9, another critical regulatory
site for brown adipogenesis. However, there was a distinct increase in methylation status
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(H3K9me2) with maternal n-3 PFUA intake (Fig 7A). Consistently, the expression of
euchromatic histone N-lysine methyltransferase 1 (Ehmt1), a methyltransferase to
H3K9(113), was significantly increased without altering expression levels of Jumonji
Domain Containing 1A (Jmjd1a, same with Kdm3a or Jmdm2a), an H3K9-specific
demethylase (Fig 7B). These site-specific epigenetic modulations by maternal n-3 PUFA
were linked with increased brown adipocyte differentiation evidenced by increased protein
expression of PPAR, fatty acid synthase (FAS) and fatty acid binding protein aP2 in the
iBAT compared to control (Fig 7C).
To further ascertain whether the modulation of H3K27Ac occurs at the
promoter/enhancer

region

of

Ucp1

and

Pgc1,

we

conducted

chromatin

immunoprecipitation (ChIP) assay by pulling down the DNA with the antibody targeting
to H3K27Ac in the murine HIB1B was more than a 2-fold enrichment at H3K27Ac in the
n-3 PUFA treated group compared with the control both in the Ucp1 enhancer region and
Pgc1-cAMP response element (CRE) binding region (Fig 7D). Taken together, these
results suggest that maternal FO exposure alters the epigenetic signature of histone
acetylation and methylation and miRNA abundance in the fetal BAT, thereby enhancing
brown-specific transcriptional program.
2.4.4 Maternal n-3 PUFA supplementation conferred long-lasting thermogenic
benefits to offspring
To gain an insight as to whether augmented BAT activity by maternal FO intake
exerts extended metabolic benefits, we conducted additional experiments. The weaned
mice with or without maternal n-3 PUFA intake were kept in the same diet without
additional n-3 PUFA until they were used for measurement of energy expenditure (at 5-
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week of age) and cold resistance (at 11-week of age) (Fig 8A). The pups that received
maternal n-3 PUFA showed significantly higher (p=0.04) energy expenditure especially at
night (Fig 8B). There were no significant differences in RER (p=0.3), implicating no
difference in the substrate use between groups (Fig 8C). Subsequently, upon mice reaching
11 weeks of age (8 weeks after maternal nutrition), mice were subjected to acute cold
treatment (6°C), and rectal temperature was recorded. At the 3-hour time point, core body
temperature was significantly higher in the maternal n-3 PUFA fed group compared to
control group (Fig 8D). Additionally, under the IR camera, pups from maternal FO group
presented a higher heat release on the surface than control mice (Fig 8E). After 24-hour
cold exposure, adipocyte morphology was visualized by H&E staining. In iBAT, fat
accumulation was lower in maternal FO-received mice than Cont, indicating the higher
BAT activity (Fig 8F). Similarly, cold exposure induced the massive brown-like adipocyte
morphology in the inguinal WAT (iWAT) in the FO group, but not in the Cont group (Fig
8F). Consistently, UCP1 protein expression was higher in both iBAT (2-fold) and iWAT
(3.5-fold) of the FO group than control (Fig 8G). The brown-specific gene expression
levels, i.e., UCP1, PGC1 and PRDM16, were maintained higher in the iBAT of the FO
group than control (Fig 8H). In addition, the browning related gene expressions of Ucp1,
Ppar, and Pgc1 were significantly higher in the iWAT of FO group than the control (Fig
8I). However, the transcript levels of sarcoplasmic/endoplasmic reticulum calciumATPase (SERCA2b), a responsive gene for calcium-dependent thermogenesis(133), was
not different between groups (Fig 8I). In addition, the two gene expressions that are
responsible for another UCP1-independent thermogenic program via creatine-driven
substrate cycle, i.e., CKMT1, CKMT2, were not detectable in both groups. These results
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suggest that maternal FO supplementation not only maintains stronger thermogenic
potential in the iBAT but also links with enhanced adaptive thermogenesis (UCP1dependent) in the iWAT. Taken together, augmented BAT formation by maternal FO may
also mediate extended metabolic benefits in later life.
2.4.5 Health beneficial effects of n-3 PUFA supplementation during pregnancy and
lactation from maternal perspective
10-week-old C57BL/6 female mice (n=4 each group) was put into breeding colony,
supplemented with either 15% total calorie from fat Control diet (5 % from soybean oil,
and 10% total calorie from palm oil,) or FO diet (5 % from soybean oil, and 10% total
calorie from fish oil, in which 3% is from n-3 PUFA), and same diets were maintained
throughout gestation and lactation. Each maternal mouse has an average of three
pregnancies before the final sacrifice period. To assess the effect of FO intake on body
weight regulation during pregnancy, body weight was measured before breeding and after
breeding. Results showed that FO intake significantly decreased the postpartum obesity
(Figure 9A). To confirm the effect of n-3 PUFA on blood lipid profile modification, same
assays were performed as in the pups. GC results demonstrated a significant decrease in n6/n-3 ratio (Figure 9B. p<0.001) in the FO supplementation mother, and a significant
decrease in arachidonic acid content in the red blood cell lipid profile (Figure 9B. p<0.001),
both of which followed the same trend in pups presented in figure 4. Additionally, there
was a significant decrease in fasting blood glucose in the FO-group mother (Figure 9C.
p<0.001), and a trend towards decrease in plasma insulin (Figure 9E).
Maternal n-3 PUFA intake also exerted health benefits to mothers in a tissuespecific manner. In liver, there was a significant decrease in both liver weight and liver
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triglycerides content, confirmed by liver H&E staining showing a dramatic decrease in
liver TG (Figure 9F, 9G, 9H). In brown adipose tissue, there was a trend towards decrease
in the BAT weight, accompanied by a decrease in lipid droplet size and content in the H&E
staining (Figure 9I, 9J). Also, there was an increase of UCP1 gene expressions in brown
adipose tissue (Figure 9K). In the epididymal white adipose tissue, there was a trend
towards lower eWAT weight and smaller lipid droplets, and no difference in UCP1
expression (Figure 9L, 9M, 9N). In subcutaneous white adipose tissue, there was a
significant decrease in sWAT weight, followed by a significant increase in sWAT UCP1
mRNA expression. Also, H&E staining showed smaller lipid droplets and a more brownlike feature in the mother subjected to FO supplementation (Figure 9O, 9P, 9Q).
2.5 Discussion
As a major nutrient, long chain fatty acid modulates energy metabolism via multiple
mechanisms, e.g. as ligands for PPARs and FFARs (134). Recently, emerging evidence
has gradually associated n-3 PUFA with increased brown adipogenesis and beige fat
conversion (28,31,37). Since brown adipose tissue was formed prenatally, and whether or
not maternal n-3 PUFA promotes fetal BAT development is unknown, this study focused
on the maternal nutrition and aimed to identify the role of maternal n-3 PUFA intake on
offspring’s BAT development and activity. This study is significant to identify the early
strategy of promoting BAT development and activity, which can be an effective approach
to retain more BAT activity to later life in pups, also combatting the risks of obesity and
metabolic syndrome. Furthermore, accumulating studies identified the thermogenic
potentials of n-3 PUFA and brown/beige adipogenic properties of a low n-6/n-3 ratio in the
diet (59,135). Here, we demonstrated that n-6/n-3 ratio was significantly decreased both in
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the pups and mother, along with a dramatic decrease in the pro-inflammatory eicosanoids
precursor, arachidonic acid (Fig.1, Fig.5), suggesting that n-3 PUFA was effectively
delivered from the mom to the pups and significantly increased the thermogenic potential
and attenuated the inflammatory eicosanoids production.
The differentiation into adipocyte has two major steps: multipotent stem cells
became committed pre-adipocyte, followed by an induction of terminal differentiation into
mature adipocytes, which are modulated by lineage-specific transcription factors, and more
importantly, some epigenetic modifications (136). Specifically, microRNA regulations
(124,137-139) and histone modifications (140-142) were suggested to play critical roles
during the brown adipocyte differentiation. MicroRNAs (miRNAs) are short-chain and
none-coding RNAs associated with post-transcriptional regulation of gene expression,
which is also closely related with various tissue development (143).The miR-193b-365
cluster was demonstrated to maintain brown adipocyte differentiation by suppressing
preadipocytes myogenic potentials and targeting at prdm16 and PPAR𝛾, which are the
brown adipogenesis positive regulators (144). Another noticeable miRNA, microRNA 30b,
was reported to induce UCP1 and CIDEA, brown-specific gene expressions, and increased
mitochondrial respiration, possibly through the mechanism of repressing Rip140, which is
a corepressor of genes associated with glucose uptake, fatty acid oxidation, as well as
mitochondrial biogenesis (26,145). Previously, our laboratory also showed that n-3 PUFA
promoted brown adipogenesis via miRNA networks (26). Here, we demonstrated that
maternal n-3 PUFA intake upregulated brown-adipogenesis functional clusters microRNA
30b, microRNA 193b, and microRNA 365 expressions, indicating that n-3 PUFA
potentiates brown adipogenesis via microRNA-mediated mechanism. Histones are a
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family of positively-charged proteins that are wrapped around by DNA to form the compact
nucleosomes, which consist of histone octamers of H2A, H2B, H3, and H4. Histone posttranslational modifications (PTMs) have been suggested to be associated with the
replication, transcription, and the repair of DNA. Also, Histone acetylation, methylation,
and phosphorylation have effects on the structure of chromatin (146). Mechanistically,
histone modifications are related with regulations of gene expressions and multiple cellular
activities, including cell differentiation and cell cycle control (147), and various diseases
such as diabetes and cancer (148,149). Recently, emerging evidence supports histone
deacetylase 1 (HDAC1) as a negative regulator of brown thermogenic program (129,150).
Here, our results indicated that maternal n-3 PUFA supplementation enhanced offspring
brown adipose tissue development by decreased HDAC1 expression and increased Histone
acetylation at lysine 27 in the brown fat, which may serve as the underlying mechanisms
by which n-3 PUFA potentiates BAT development.
The health benefits of maternal n-3 PUFA fatty acids intake on offspring have long
been received attention by different researchers (20,21,151-153). It has been demonstrated
that adequate n-3 PUFA during pregnancy and early childhood is of vital importance (154).
There was a maternal feeding study performed in C57BL/6 mice suggested that maternal
n-3 PUFA intake reduced pups body fat at weaning. Additionally, there was a significant
increase in the insulin sensitivity, and a significant decrease in the plasma cholesterol and
triglycerides levels in pups at 15 weeks of age (155). However, the health beneficial effects
of n-3 PUFA of maternal intake on offspring BAT development remain elusive. Here, we
demonstrated in mice model that maternal n-3 PUFA supplementation was effectively
delivered to pups, reduced fat accumulation, promoted brown adipogenesis-related gene
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UCP1, PGC1-, CIDEA, PRDM16, and GPR120 expressions, and promoted brown
adipose tissue-specific protein expression (Fig.1-4).
Although accumulating evidences regarding n-3 PUFA promotes brown/beige
adipose tissue thermogenesis have been well-elucidated in mouse and in vitro cell models,
the implication of this effect in human remain to be clarified. There are some studies
supporting that n-3 PUFA administration in human could reduce body weight and plasma
triglycerides, decrease inflammation, and increase insulin sensitivity (78,156-162).
However, the amount of human studies directly associating n-3 PUFA with energy
expenditure/thermogenesis is limited. Interestingly, there are some human studies focusing
on the health beneficial effect of maternal n-3 PUFA intake during pregnancy and lactation
on offspring. A human study done by Foster et al. investigated the effect of DHA 800
mg/day on women at 25-29 weeks gestation until the last day of the pregnancy. Results
indicated that arachidonic acid, as the precursor for pro-inflammatory eicosanoids, was
decreased and DHA was increased at 36 weeks of pregnancy red blood cell lipid profile
analysis. There was no significant increase in the direct developmental indicators (body
weight, BMI) at 2 years or 4 years age. However, there was a significant correlation
between BMI z-score and the length of breastfeeding in months at both two and four years
(100). These findings indicated that DHA can be effectively delivered to the offspring, and
that DHA has anti-inflammatory effect. Also, in another feeding study in pregnant women
by Bergmann et al. (163), normal maternal diet supplemented with 300mg n-3 PUFA
lowered body weight and body mass index at offspring in 21 months of age. In another
maternal feeding study, mothers supplemented 1.83g DHA and 0.80g EPA from gestation
to the end of lactation, the results showed no difference in the body mass index at age 7
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(164). Taken together, many researches have been done regarding the health-beneficial
effect of n-3 PUFA in human, influences of maternal n-3 PUFA intake on offspring seem
to be promising but remain to be investigated. Despite some conflicting results in the
human feeding studies, the underlying reasons may due to the complexity of human study
design or the races, gender, or health conditions, individual difference of the human object,
and the length of the study and the time of measurements might contribute to the conflicting
results. Future human studies are needed to confirm the effect of n-3 PUFA on
thermogenesis and energy expenditure at the clinical study level, and also the effect of
maternal n-3 PUFA on offspring’s brown adipose tissue development and from the energy
expenditure perspective.
In summary, maternal n-3 PUFA supplementation was effectively delivered to pups
and increased n-3 PUFA concentration in the pup’s blood, at the same time, decreasing the
pro-inflammatory eicosanoids precursor arachidonic acid. Additionally, maternal n-3
PUFA intake significantly decreased fat accumulation and increased BAT activity,
confirmed by brown specific markers in both gene and protein expressions. Interestingly,
microRNA 30b, 193b, and 365 were upregulated in the maternal n-3 PUFA
supplementation. Concomitantly, Histone modifications at acetylation at K27 and dimethylation at K9 were increased, which may serve as mechanisms by which maternal FO
intake potentiates offspring’s brown adipose tissue development. This study offers an
insight for the role of maternal n-3 PUFA supplementation on fetal brown adipose tissue
development, non-shivering thermogenesis, and the long-lasting metabolic benefits
extended to later life of the offspring. This study also provides scientific foundation for
further clinical trials regarding the health benefits of n-3 PUFA.
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CHAPTER 3. DISCUSSION, LIMITATION, AND FUTURE STUDIES
3.1 Discussion
Emerging evidence suggests that n-3 PUFA potentiate thermogenic programs in
brown and beige adipocytes (28,31,37). Although pregnancy is a critical time frame for
BAT development (112), it is largely unknown whether the availability of n-3 PUFA to the
fetus could modulate embryonic BAT development. This study is designed to identify the
effects of maternal n-3 PUFA intake on fetal BAT development, potential mechanisms,
and long-term metabolic consequences. Here, we demonstrated that maternal n-3 PUFA
intake altered the neonates’ FA profiles by reducing the n-6/n-3 PUFA ratio in the neonates,
suggesting that n-3 PUFA is effectively delivered from mothers to the pups (Fig 4). The
maternal n-3 PUFA intake (3%) was sufficient to potentiate transcriptional programming
of the brown adipogenesis (Fig 5) via mechanisms involved in miRNA production (Fig 6)
and histone modification (Fig 7). Furthermore, the augmented thermogenic activities
endowed offspring with long-lasting metabolic benefits (Fig 8). Based on these results, we
proposed that maternal n-3 PUFA intake is a molecular driver in promoting epigenetic
liability of brown differentiation via a two-pronged mechanism through brown-specific
miRNA biogenesis and histone modulation (Fig 9). It is intriguing to evaluate the potential
of prenatal BAT as a new and feasible therapeutic target to promote thermogenic energy
expenditure via maternal dietary intervention.
3.1.1 Metabolic relevance of BAT in energy metabolism and use the rodent as a
feasible model
Human BAT depots are found in the deeper neck (cervical), supraclavicular,
perirenal, axillary, and paravertebral areas (115-117). Human supraclavicular BAT
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possesses 50-times greater respiratory activities than white adipose tissue (WAT) (2).
These BAT depots are comprised of 1.5% of total body mass (roughly 5% of total fat mass),
and up to 90% depots could be activated BAT (118). By using the

18

F-labeled

fluorodeoxyglucose positron emission tomography/computerized tomography (PET/CT),
substantial brown fat activities are found in ~96% of healthy lean adults, but in only ~20%
of obese subjects (67), emphasizing the metabolic significance of BAT in adiposity control.
By using stable isotope methods, it has been revealed that human BAT directly participates
in whole-body lipolysis and thermal regulation in response to both prolonged (165) and
mild cold exposure (166). An image-guided mapping of rodent adipose depots reveals the
topological analogy of BAT between rodents and humans (119), which provides the
feasibility to use rodent in studying human BAT. Supporting this notion, comparable
functional analysis demonstrated that human supraclavicular BAT features the functional
similarity with rodent interscapular BAT regarding mitochondrial activity and thermogenic
potential. It is also shown that brown adipose tissue in both human and rodents exerted
comparable UCP1 activity per mitochondrion (2).
In terms of timeline for BAT development, mouse BAT is formed at the last week
of pregnancy out of approximately 21-day of total gestation period. Despite humans have
longer gestation period than rodents, late pregnancy is the critical time for human BAT
formation (4,120). In humans, BAT appears at the mid-gestation period and its BAT
development mostly happens at the last trimester of pregnancy (110). BAT expands its
maximum size at the early postnatal period, and stays fairly stable in size until adolescence,
and degenerates into white adipose tissue with the progression of age (110). Given the
developmental similarities of BAT between rodents and humans, the regulation of
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interscapular BAT in rodents during pregnancy seems to be translatable, at least offering
an important insight for human BAT regulation.
3.1.2 Regulation of fetal BAT development by maternal n-3 PUFA intake
The health benefits of maternal n-3 PUFA intake on offspring have received
extensive attention (21,151,153). Since the synthesis of n-3 PUFA in the fetus side is
limited, the transfer of n-3 PUFA cross the placenta from the mother to the fetus is vital
and necessary when it comes to maternal nutrition (167). The maternal supplementation of
n-3 PUFA increases the n-3 PUFA concentration in placenta and uterus cord blood,
suggesting that maternal n-3 PUFA is effectively transferred to fetus prenatally (168).
Despite the multiple metabolic benefits of maternal n-3 PUFA intake to the offspring
(156,157,159,162), the effects of maternal n-3 PUFA intake on modulating the fetal BAT
development and thermogenic activities remain elusive. Indeed, per our knowledge, our
study is the first to demonstrate maternal n-3 PUFA supplementation decreases n-6/n-3
ratio in the neonatal BAT (Fig 2C). Our results also provide scientific evidence that
maternal n-3 PUFA supplementation promoted brown adipogenesis-related gene
expressions including UCP1, PGC1, CIDEA, and PRDM16 (Fig 2). It is notable that
activation of brown-specific genes in the iBAT relies on GPR120, a membrane sensor for
n-3 PUFA. There was a robust increase in GPR120 mRNA expression in iBAT in response
to the maternal supply of n-3 PUFA in both genders. These results align with our previous
finding that EPA-induced brown adipogenesis is dependent on GPR120 (26). It is also
compatible with the literature showing that knockout of GPR120 or treatment of GPR120
antagonist dampened the thermogenic activities (31). Consistent with this notion, genetic
ablation of GPR120 in mice results in hepatic steatosis and insulin resistance (43). In
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humans, lack of GPR120 signaling activity due to a genetic mutation in the GPR120 gene
(p.R2700H) is correlated with increased risk of obesity (43).
Intriguingly, augmented BAT activity by maternal n-3 PUFA was sustained for at
least 8 weeks post-weaning (Fig5); the pups received the maternal n-3 PUFA
supplementation not only maintained the higher BAT activities in the iBAT but also
exerted higher adaptive thermogenesis in the iWAT (Fig5). Our results are consistent with
the recent report that low perinatal n-6/n-3 ratio is important to attenuate susceptibility
against diet-induced obesity in adult offspring (101). Human studies also support an inverse
correlation between maternal n-3 PUFA intake and prevalence of childhood obesity.
Specifically, a higher risk of childhood obesity was correlated with a higher maternal n6/n-3 fatty acid diet ratio, while maternal n-3 PUFA intake was linked with a lean body fat
mass of children (97-100). In contrast, there exist some inconsistent human studies that fail
to observe the negative correlation between maternal n-3 PUFA and adiposity of the
offspring (169-171). These studies might be compounded by the variables such as
supplementation periods, dose, and the ratio of DHA to EPA. Future human clinical trials
with the long-term follow-up research design are warranted to establish the effect of
maternal n-3 PUFA on thermogenesis and energy expenditure at the time of birth,
childhood and adolescence.
3.1.3 Epigenetic regulation of BAT by early exposure to maternal n-3 PUFA
In terms of the underlying mechanism, we propose that maternal n-3 PUFA intake
promotes brown transcriptional program of neonatal BAT via the synergistic action of
miRNAs and histone modifications.
MiRNAs are short non-coding RNAs associated with post-transcriptional
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regulation of gene expression, which play a critical role in BAT differentiation (124,137139). The blockage of miRNA biogenesis by adipocyte-specific deletion of dicer
significantly impairs BAT development (172). The miR-193b/365 was first identified as a
brown-specific miRNA cluster to promote brown adipogenesis by suppressing the
myogeneic-lineage differentiation in the Myf5+ precursor cells(173). Also, miR-30b was
reported to induce brown-specific gene expressions and increased mitochondrial
respiration through degradation of the transcriptional corepressor receptor-interacting
protein 140 (RIP140) (26,145). Previously, we demonstrated the cell-autonomous function
of n-3 PUFA in promoting brown adipogenesis in the primary brown precursor cells,
leading to an increase of clusters of brown-specific miRNAs including miR-30b and miR193b/365 (26). In agreement with our in vitro study, n-3 PUFA exposure during pregnancy
recapitulated the involvement of the same profile of miRNAs including miR-30b, and miR193/365 cluster (Fig 3A). Interestingly, augmented BAT thermogenesis is correlated with
an increase of the Drosha gene and protein expression (Fig 3C, D). Drosha is a ribonuclease
and a critical component of the microprocessor for initiating the cleavage of pri-miRNA
into stem-loop pre-miRNA (174). It is conceivable that n-3 PUFA availability may alter
microprocessor activity resulting in pre-miRNA biogenesis in the iBAT, thereby
augmenting the microbiome of iBAT. In supporting this idea, deletion of fat-specific
DGCR8, a subunit of the microprocessor complex that recognizes and mediates the
processing of pri-miRNA into pre-miRNA, resulted in defective BAT formation and severe
cold intolerance (175). We are currently investigating whether maternal n-3 PUFA intake
alters the miRNA processor activities, thereby increasing the pri-miRNAs processing rate
in the nucleus.
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Histone modifications represent another important mode of epigenetic regulation
of transcription in directing cell-lineage specification and tissue-specific gene expression.
Accumulating evidence suggests that BAT development is governed by dynamic changes
in post-translation modification via acetylation and methylation on the N-terminal tail
region of histones(126). In general, histone acetylation of lysine (K) side chains decreases
positive changes and reduces chromatin compactness, thereby contributing to
transcriptional activation. Histone acetylation is regulated by the balance between histone
acetyltransferase (HAT) and histone deacetylases (HDACs). Jin et al. showed that
Gcn5/PCAF, a HAT enzyme, facilitates brown adipogenesis (176). The inhibition of
HDAC1 (129) or HDAC9 is linked with transcriptional activation of brown adipogenesis
(131,153). In contrast, deacetylase activity of HDAC3 is required for thermogenic adipose
program (177). Histone methylation occurs on lysine (K) or arginine (R) residue, thereby
altering the DNA accessibility to the binding of chromatin modifiers and transcription
factors or epigenetic readers. It is important to note that site-specific H3K9 methylation by
G9a represses brown differentiation (151), while methyl transfer by EHMT1 promotes
BAT-selective thermogenic program (113). Controversially, deletion of demethylase
JMJD1a, demethylase at H3K9, is linked with obesity (152,178). Another critical
epigenetic site for histone methylation is H3K27. The reduction of H3K27me3 by
demethylase enzymes of UTX (129) or JMJD3 (132) is essential for brown adipogenesis.
Recently, the dynamic interplay between histone acetylation and methylation at H3K27was
revealed during brown adipogenesis. The adrenergic stimulation induced dissociation
of HDAC1, resulting in increased H3K27 acetylation followed by H3K27me3
demethylation thus allowing transcription in the isolated brown precursor cells (129).
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Most

aforementioned

epigenetic

histone

modifications

during

brown

differentiation were derived from the animals or cells with specific deletions of epigenetic
writers (enzymes that catalyze the addition of epigenetic marks) or erasers (enzymes that
catalyze the removal of epigenetic marks). To our surprise, little information is available
about how environmental factors such as diet modify epigenetic markers for brown
adipogenesis. The transcriptional activation of the fetal brown thermogenic program by n3 PUFA were linked with altered PTMs, i.e., enhanced H3K27Ac and diminished
H3K27me3, through the coordinated modulation of epigenetic erasers between HDAC1
and JMJD3. In addition, the enhanced H3K9me2 status by n-3 PUFA intake was associated
with an increase of epigenetic writer EHMT1 without altering the demethylase JMJD1 (Fig
4A, B). These results unanimously suggest that prenatal n-3 PUFA exposure serves as an
epigenetic modulator, thereby potentiating transcriptional brown thermogenic program.
3.2 Limitation and future studies
One caveat of our study design is that we cannot distinguish the effects of prenatal
n-3 PUFA exposure from the n-3 PUFA supply through lactation. Aware of this limitation,
we plan to conduct new experiments to address the separate role of prenatal BAT
development and lactation by collecting BAT at birth or swapping the pups during the
lactation period. To ascertain the long-term metabolic benefits, we are currently
investigating whether maternal n-3 PUFA intake confers the resistance against high fat
diet-induced obesity and insulin resistance in adulthood. Despite numerous indications in
experimental animals, our current understanding regarding the thermogenic function of n3 PUFA in humans is inconsistent (97-101,169-171). In particular, the role of maternal n3 PUFA supplementation on thermogenic activities in offspring, presumably through
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epigenetic modifications, has yet to be established. As pregnant women are recommended
to take approximately 600~800 mg of n-3 PUFA daily during pregnancy (3,5), the exact
role of n-3 PUFA on fetal BAT development and its long-term metabolic benefits through
enhanced brown thermogenic potential should be addressed in humans. Here, we presented
initial evidence that fetal BAT development could be a feasible therapeutic target to
attenuate childhood obesity via maternal n-3 PUFA supplementation.
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Figure 4 Maternal n-3 PUFA supplementation decreased offspring’s WAT
accumulation and altered blood lipid profile at the time of weaning. A-C. Effects of
maternal n-3 PUFA supplementation on body weight, liver weight, epididymal WAT, and
interscapular BAT weight from all pups (A, n=18 each group), female pups (B, n=8) and
male pups (C, n=10). D. n-6/n-3 PUFA ratio by GC analysis. E. Arachidonic acid
content (%). F. Plasma glucose level. G. Insulin concentration by ELISA. H. cAMP
concentration. All data was expressed as mean ± SEM.* p<0.05, **p< 0.01, and ***P <
0.001 by Student’s t-test.
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Figure 5 Maternal n-3 PUFA supplementation enhanced BAT development in
offspring at the time of weaning. A. Gross image of iBAT without (Cont) or with (FO)
maternal n-3 PUFA supplementation. B. Representative microscopic images with H&E
staining of iBAT. C. n-6/n-3 PUFA ratio and arachidonic acid (ARA) content (%) in the
iBAT (left) by GC analysis. D-F. Brown signature gene expressions of Ucp1, Gpr120,
Pgc1-α, Cidea, and Prdm16 in all pups (D), female pups (E) and male pups (F) by qPCR.
G. Western blot pattern of UCP1, GPR120, and PRDM16 in the iBAT (left). Relative
protein intensities to -actin quantified by Image J (right). H. Relative mitochondrial DNA
to genomic DNA in the iBAT (n=6). All data are shown as mean ± SEM. *p < 0.05, **p <
0.01 and ***p < 0.001 by Student’s t-test.
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Figure 6 Maternal n-3 PUFA supplementation promoted brown adipogenesis via
miRNA biogenesis at the time of weaning. A. qPCR analysis of miRNAs of miR-30b,
193b, and 365 in all pups (n=18), B. Schematic diagram of the nuclear processing of primiRNA by Drosha. C. Drosha mRNA expression (n=8) by qPCR, D. Protein levels of
Drosha in iBAT (upper), and its relative intensity to -actin by Image J (lower). All data
are shown as mean ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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Figure 7 Maternal n-3 PUFA supplementation promoted brown adipogenesis via
histone modifications at the time of weaning. A. Western blot pattern of epigenetic
markers of HDAC1, H3K27Ac, H3K27Me3, H3K9Ac, H3K9me2 (left). Image J was used
to determine the relative status of histone acetylation and methylation at the H3K27 and
H3K9 (right). B. qPCR analysis of epigenetic enzymes of histone methyltransferase
Ehmt1, and demethylases of Jmjd3 and Jmjd1. C. Western blot pattern of adipocyte
proteins of PPAR, FAS, and aP2 (left). The membrane intensity was quantified by Image
J (right). D. Enrichment of H3K27Ac at the promoter region of Ucp1 and Pgc1by ChIP
assay in the HIB1B cells that were differentiated with either vehicle (BSA) or EPA (n=4).
All data are expressed as mean ± SEM. *p< 0.05, **p< 0.01, ***p<0.001 by Student’s ttest.
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Figure 8 Maternal n-3 PUFA supplementation was associated with metabolic
improvement in the later life of offspring. A. Schematic presentation of experimental
design. The pups received maternal control diet (Cont)- or FO-diet (FO) were weaned at 3
weeks age, and maintained until 11 week-old with no additional dietary modification. B.
Average energy expenditure for 4 days measured by metabolic cages (n=5) C. Average
RER (VCO2/VO2) values for 4 days measured by using metabolic cages (n=5). D. Core
body temperature measured by rectal temperature upon exposure to cold temperature (6°C)
for 3 hours (n=6). E. Heat release captured by IR camera upon 3-hour cold exposure. F.
Representative images with H&E staining of iBAT and iWAT after 24-hour exposure to
cold temperature (6°C). Red arrows indicate the emergence of brown-like structure within
iWAT. G. Western blot pattern of UCP1 in the iBAT and iWAT after 24-hour cold
exposure (left). Relative UCP1 levels were quantified by Image J (right). H. Brown
signature gene expressions of Ucp1, Pgc1α, and Prdm16 in the iBAT after 24-hour cold
(a
responsible gene for calcium-cycling dependent thermogenesis) in the iWAT after 24-hour
cold exposure (n=6). All data are expressed as mean ± SEM. *p< 0.05, **p< 0.01,
***p<0.001 by Student’s t-test.
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Figure 9 Health benefits of n-3 PUFA during pregnancy and lactation from maternal
perspective. A. Body weight changes after an average of 3 pregnancies. B. Upon sacrifice,
red blood cell lipids were extracted and detected for n-6/n-3 fatty acids ratio Band
arachidonic acid content. C. Fasting blood glucose and plasma was measured for insulin
concentration. D. Liver weight, triglycerides content, and H&E staining were measured.
E. Subcutaneous WAT weight, Ucp1 expression, and H&E staining. F. iBAT weight, H&E
staining, and Ucp1 expression were presented. All data were shown as mean ± SEM. * P
< 0.05; ** P < 0.01; *** P < 0.001 by Student’s t -test.
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Figure 10 The proposed mechanism by which maternal n-3 PUFA supplementation
potentiates fetal BAT development via epigenetic modulation. Maternal n-3 PUFA
intake provides n-3 PUFA to the fetus across the placenta. In fetus, activation of GPR120,
a membrane sensor for n-3 PUFA, triggers at least two epigenetic modulations, histone
modifications, and miRNA biogenesis. Fetal availability of n-3 PUFA increases cAMP
levels and alters PTM marks of H3K27Ac and H3K9me2, presumably with modulation of
epigenetic enzymes including reduced HDAC1, resulting in enhanced transcriptional
activation for brown specific genes, i.e., Ucp1, Prdm16, Ppar, and Pgc1. The augmented
transcriptome by histone acetylation concurrently increases miRNA-gene transcription and
Drosha expression, leading to enhanced nuclear pri-miRNA processing and mature
miRNA biogenesis. With this concerted action of histone modification and miRNA
regulation, early exposure to n-3 PUFA potentiates transcriptional program of the fetal
BAT, which may mediate to long-lasting metabolic benefits in later life.
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Table 1 Fatty acid composition of Control diet (Cont) and N-3 PUFA (FO) diet
Cont

FO

Carbohydrate

65 (62.1)

65 (62.1)

Protein

20 (19.8)

20 (19.8)

Fat

15 (6.8)

15 (6.8)

3.9 kcal/g

3.9 kcal/g

Myristic acid C14:0

0.89

7.37

Palmitic acid (PA) C16:0

35.99

18.49

Palmitoleic acid C16:1(n-7)

0.13

10.72

Stearic acid C18:0

5.91

5.44

Oleic acid C18:1 (n-9)

23.86

14.03

Linoleic acid C18:2 (n-6)

28.84

14.74

Linolenic acid C18:3 (n-3)

4.19

3.17

Eicosapentaenoic acid C20:5 (n-3)

0.03

13.36

Docosahexaenoic acid C22:6 (n-3)

0.15

12.70

SFA

42.79

31.30

MUFA

23.99

24.74

PUFA

33.21

43.96

Total (n-6) PUFA (%)

28.84

14.74

Total (n-3) PUFA (%)

4.37

29.22

(n-6): (n-3) ratio

6.60

0.50

% Calorie (in % in gram diet)

Energy Density
Fatty acid profile (%)

Fatty acid composition
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APPENDIX:
Abbreviations
ADRB2—2-adrenoceptors
ADRB3—3-adrenergic receptor
ALA—-linolenic acid
ARA—Arachidonic acid
BMI — Body mass index
cAMP—Cyclic adenosine monophosphate
ChIP— Chromatin immunoprecipitation
CIDEA— Cell death-inducing DNA fragmentation factor α-like effector A
COX—Cyclooxygenases
CRE— cAMP response element
DAG— Diacylglycerol
DHA—Docosahexaenoic acids
DPA — Docosapentaenoic acid
EE— Energy expenditure
EHMT1— Euchromatic histone N-lysine methyltransferase 1
EPA—Eicosapentaenoic acids
eWAT— Epididymal white adipose tissue
FA—Fatty acids
FAS— Fatty acid synthase
FDG — 18F-2-deoxy-glucose
FGF21— Fibroblast growth factor 21
FO— Fish oil
GC — Gas Chromatography
GPR120— G-protein-coupled receptor 120
hADS — Human adipogenic stem cells
HAT— Histone acetyltransferase
HDAC1— Histone deacetylase 1
HF—High fat
iBAT— Interscapular brown adipose tissue
ILC2s — Type 2 innate lymphoid cells
iWAT— Inguinal white adipose tissue
JMJD3— JmjC domain-containing protein 3
MUFA— Monounsaturated fatty acids
N-3 PUFA— Omega-3 polyunsaturated fatty acids
PET— Positron emission tomography
PGC1— Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
PGI2— Prostacyclin
PPAR— Peroxisome proliferator-activated receptor gamma
RIP140— Receptor-interacting protein 140
PRDM16— PR domain containing 16
PTM— Post-translational modifications
PVDF — Polyvinylidene fluoride
RER — Respiratory exchange ratio
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RMR — Resting metabolic rate
SFA— Saturated fatty acids
SNS — Sympathetic nervous system
SV— Stromal vascular
TRPV1—Transient receptor potential vanilloid receptor1
UCP1— Uncoupling protein 1
VCO2— Carbon dioxide production
VEGF— Vascular endothelial growth factor
VO2— Oxygen consumption
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